The research group at the Department of Clinical and Molecular Genetics, Hiroshima University Hospital...Hiroshima University
Overview of a framework for prioritizing variants of uncertain significance (VUS) identified by comprehensive genomic pr...Hiroshima University
BRCA2:c.67G>C is associated with aberrant splicing and an exceptional response to platinum-based chemotherapy...Hiroshima University
Nuclear medicine physician James Nagarajah from Radboudumc in the clinics...Radboud University Medical Center
